Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : email@example.com
Limited information is currently available on EMB-01, a putative bispecific antibody against EGFR and cMET (Feb, 2019).
|Drug Name||Trade Name||Synonyms||Drug Classes||Drug Description|
|EMB-01||EMB01|FIT-013a|EMB 01||EGFR Antibody 42 MET Antibody 23||EMB-01 is a bispecific antibody against EGFR and MET, which prevents tumor cell proliferation (NCI Drug Dictionary).|
|Molecular Profile||Indication/Tumor Type||Response Type||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|
|Clinical Trial||Phase||Therapies||Title||Recruitment Status||Covered Countries||Other Countries|
|NCT03797391||Phase Ib/II||EMB-01||A Dose Escalation With Expansion Study of EMB-01 in Participants With Advanced/Metastatic Solid Tumors||Recruiting||USA||1|
|NCT05176665||Phase Ib/II||EMB-01||EMB-01 in Patients With Advanced/Metastatic Gastrointestinal Cancers||Recruiting||USA||1|